Pharmaceutical - Antibiotics and Infectious diseases, Global


Popular Filters

Antibiotic crisis needs united global response, say UK experts


Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale…

Antibiotics and Infectious diseasesGlobalHealthcarePharmaceuticalResearch

Antibiotic resistance is a serious public health threat according to WHO global report

Antibiotic resistance is a serious public health threat according to WHO global report


Resistance of antibiotics is a serious threat happening now around the world, according to The World…

Antibiotics and Infectious diseasesGlobalHealthcarePharmaceutical

Global Fund taps pharmaceutical expertise in China


The Global Fund is deepening its partnership with China by tapping the expertise of Chinese pharmaceutical…

Anti-viralsAntibiotics and Infectious diseasesChinaGlobalMarkets & MarketingPharmaceuticalProductionRegulation

IFPMA and the Global Fund collaborate to help protect patients from fake medicines


The International Federation of Pharmaceutical Manufacturers and Associations and the Global Fund to…

Anti-viralsAntibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalRegulationTropical diseases

Global Fund-proposed shake-up to drug pricing framework risks middle-income countries paying more, says MSF

Global Fund-proposed shake-up to drug pricing framework risks middle-income countries paying more, says MSF


Ahead of the Global Fund replenishment conference in Washington DC this week, international medical humanitarian…

Anti-viralsAntibiotics and Infectious diseasesGlobalPharmaceutical

Rise in infections means hepatitis C market is expected to peak at $15.5 billion in 2022


The hepatitis C market is forecast to increase by a massive 230% in the next nine years, according to…

AbbVieAntibiotics and Infectious diseasesBristol-Myers SquibbGilead SciencesGlobalJohnson & JohnsonMarkets & MarketingPharmaceuticalsofosbuvir

UNITAID market power results in price cuts of up to 80% for HIV/AIDS, TB and malaria products


UNITAID's approach to transform health product markets has delivered price reductions of up to 80% for…

Anti-viralsAntibiotics and Infectious diseasesGenericsGlobalHealthcarePharmaceuticalPricingTropical diseases

Infectious disease treatments market driven by growth in middle-income to low-income countries


The infectious disease treatments market increased at a compound annual growth rate (CAGR) of 6.9% between…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalVaccines

Clinigen and Theravance deal on Vibativ; Cubist expands rights to ceftolozane


UK-based Clinigen Group (LSE: CLIN ) and Theravance (Nasdaq: THRX) of the USA have entered into an exclusive…

Antibiotics and Infectious diseasesAstellas PharmaceftolozaneClinigen GroupCubist PharmaceuticalsEuropeGlobalLicensingPharmaceuticalTheravanceVibativ

Major constraints in the hospital-treated infections drug market include generic erosion


The hospital-treated infections (HTI) drug market, the loss of patent protection for key branded products…

Antibiotics and Infectious diseasesGenericsGlobalMarkets & MarketingPharmaceuticalResearch

Further initiatives from GlaxoSmithKline to help tackle global health challenges; TB deal with Aeras


UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday announced new measures to further advance its commitment…

Antibiotics and Infectious diseasesGlaxoSmithKlineGlobalHealthcarePharmaceuticalResearchVaccines

World antibacterials market to grow to $43.8 billion in 2016, says Visiongain


World revenues for antibacterial drugs will reach $43.81 billion in 2016. Between 2010 and 2022, the…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceutical

Key hospital-infections markets set to grow to over $4 billion in 2020; report


Despite market constraints that include intensified competition, generic erosion and an increasingly…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top